The Clinical Times
The Front Page of Medicine

Latest medical news · page 113

The latest headlines across every section, pulled from official and open-access sources.

MedCity News · Jul 2, 2026

Color Broadens Cancer Expert Medical Opinion Program

Color expanded its Expert Medical Opinion program with a new peer-to-peer service that connects oncologists with cancer specialists. The post Color Broadens Cancer Expert Medical Opinion Program appeared first on MedCity News .

FDA Drugs · Jul 2, 2026

Drug Alerts and Statements

See updates from CDER on fast-moving issues and learn about CDER's work to enhance public health

MedCity News · Jul 2, 2026

With New Phase 3 Data, Roche Claims an Edge Over Amgen and BMS Lung Cancer Drugs

Roche’s divarasib was designed offer greater potency and selectivity to KRAS G12C compared to first-generation drugs in this class marketed by Amgen and Bristol Myers Squibb. The Swiss pharma company now plans to submit the data to regulators for review as a potential treatment for non-small cell lung cancer driven by this particular mutated protein. The post With New Phase 3 Data, Roche Claims an Edge Over Amgen and BMS Lung Cancer Drugs appeared first on MedCity News .

ADA (Diabetes) · Jul 2, 2026

The American Diabetes Association Requests OMB Withdraw Proposed Rule Changing Guidelines for Federal Financial Assistance

The American Diabetes Association Requests OMB Withdraw Proposed Rule Changing Guidelines for Federal Financial Assistance mcarmody Thu, 07/02/2026 - 18:03 Official Statement The American Diabetes Association Requests OMB Withdraw Proposed Rule Changing Guidelines for Federal Financial Assistance ARLINGTON, Va. July 2, 2026 Today, the American Diabetes Association ® (ADA) submitted its official public comment on the White House Office of Management and Budget (OMB) proposed rule on the Guidance for Federal Financial Assistance. In its comment, the ADA expressed significant concern over the…

WHO · Jul 2, 2026

WHO adds first diagnostic test for Ebola Bundibugyo virus to its Emergency Use Listing

Today, the World Health Organization (WHO) has added the first molecular diagnostic test for Bundibugyo virus (BDBV) to its Emergency Use Listing (EUL) . The test detects the virus by identifying its genetic material in blood samples, helping confirm infection rapidly and accurately. WHO’s EUL procedure assesses the quality, safety and performance of essential health products based on the available evidence, while ensuring they meet minimum international standards and address the needs of low- and middle-income countries. Through this mechanism, WHO aims to accelerate access to reliable…

MedCity News · Jul 2, 2026

Debunked Episode 28: A Little More Transparency, A Little More Action

Debunked Podcast co-hosts Arundhati Parmar and Samir Batra discussed some of the takeaways from UnitedHealth Group’s press event, transparency, and pharma company Lilly’s efforts to hold hospitals accountable in the 340B drug discount program. The post Debunked Episode 28: A Little More Transparency, A Little More Action appeared first on MedCity News .

FDA Drugs · Jul 2, 2026

Patient Education

Generic medications are just as safe and effective as their brand-name counterparts, and often cost less. To help educate patients about FDA’s rigorous review process, the economics of pricing, and related issues, FDA offers a range of educational materials, including videos, graphics, fact sheets,.

ADA (Diabetes) · Jul 2, 2026

Meet Roe: Proving Type 1 Diabetes Can’t Stop a Division I Dream

Meet Roe: Proving Type 1 Diabetes Can’t Stop a Division I Dream mseibold Thu, 07/02/2026 - 15:17 Type 1 Share Your Story By sharing your story, you help us raise awareness of diabetes so we can bend the curve on it once and for all. Will you help us awaken the world? Share Your Story

← NewerOlder →

Back to the live front page